Neogen acquires BioLumix

neogen_earnings_blog Neogen Corporation (NASDAQ: NEOG) announced today that, effective Sept. 30, it has acquired all the outstanding stock of BioLumix, Inc., an Ann Arbor, Mich.-based manufacturer and marketer of automated systems for the detection of microbial contaminants.

The BioLumix business will be consolidated with Neogen’s closely related Soleris® technology, which is widely used for the detection of spoilage organisms in several food industries, as well as the nutraceutical market. The Soleris system was the first in the industry used for the detection of microbial contamination based upon an innovative application of well-accepted classical microbiology.

“Combining of the Soleris and BioLumix technologies, market bases, and outstanding technical staffs will greatly enhance both businesses and offer significant labor saving rapid solutions for the food, pharmaceutical, and personal care businesses,” said James Herbert, Neogen’s chief executive officer and chairman. “The combination also settles litigation of seven years between the two companies, and benefits existing customers of both companies moving forward.”

The BioLumix test platform includes an instrument where test vials are incubated and automatically read for results, and an automatic system to alert users to sample results. The basic unit accommodates 32 different test vials at a time and can be combined in modules to accommodate up to 1,000 different samples simultaneously.

Test vials are the consumable portion of the platform and contain growth media and indicators for a number of different microorganisms. A sample is simply added to the vial, and the vial inserted into the instrument. BioLumix currently has 19 different microorganism tests. Specialized software shows test results as soon as detections occur, and avoids the need for involvement from a hands-on operator. The software also creates and maintains all the necessary audit trails to comply with various government regulations.

Terms of the agreement were not disclosed.

For the full press release, click here.

BioLumix Simplified, Rapid, Automated Microbiology on Display at Ingredient Marketplace 2014 in New York

BioLumix Simplified, Rapid, Automated Microbiology on Display at Ingredient Marketplace 2014 in New York

May 5, 2014 by Linda Schmaler & Paul Dudley
Since its beginnings in 2006, BioLumix, Inc. has been on the leading edge of technology in the world of microbiology.  On June 2 – 3, 2014, that technology will be on display at Ingredient Marketplace 2014 at the Jacob Javits Center in New York City.  This year, BioLumix has added a new assay to its already robust line of test vials: Listeria

Ingredient MarketplaceSupplySide Marketplace has changed its name to Ingredient Marketplace, and is built upon the theme, “What’s Inside Matters.”  With consumers seeking safer, healthier products, manufacturers today are more focused than ever on providing their products to satisfy their demands while at the same time coming up with effective ways to improve both their products and the means by which they are brought to market.  This is where BioLumix can make a difference!

The BioLumix System monitors changes in broth medium in which target organisms grow.  Microbial metabolism causes the reagents on the proprietary vial to change their color or fluorescence, and real-time monitoring of these changes by optical sensors provide immediate feedback.  This means that a sample that tests above spec is known right away.  The optical sensor monitors vials in the testing unit 10 times per hour.

BioLumix provides test vials for a wide range of assays:

  • Total Aerobic Count
  • Coliform
  • Enterobacteriaceae
  • Yeast and mold count
  • Gram negative bacteria
  • Heterotrophic bacteria
  • Sterility testing
  • Preservative efficacy test
  • Microbial limits
  • Suitability testing
  • Pseudomonas aeruginosa
  • Staphylococcus aureus
  • Escherichia coli
  • Listeria
  • Bacillus cereus
  • Lactic acid bacteria

Listeria VialThe impact of the BioLumix automated rapid microbiology system can be realized in a wide variety of benefits:

  • Ready-to-use vials come with a Certificate of Analysis
  • All confirmation steps are done directly from the vial
  • Certificate of Analysis (C of A) for all assays produced within 48 hours
  • Customized Validation Package in compliance with USP <2021>, <2022>, <2023>, or USP <61> and <62>
  • Automated real-time monitoring for rapid results
  • Ease-of-use – the system can be operated by non-microbiologists, which can allow microbiologists to perform other tasks
  • Centralized data processing and archiving for easy management of results
  • Same-day Total Aerobic Counts and Coliform results
  • Yeast and Mold results within 48 hours
  • Objectionable organisms can be tested on the same platform

These benefits translate into significant business advantages, such as early detection of problems, faster product release, product validation, improvements in factory and lab capacity, lower cost of inventory, and reduced cost of capital.  In addition, all installations include real-time, 24/7 support by a dedicated BioLumix microbiologist.

Please join us at Ingredient Marketplace 2014, and be sure to stop by our booth (417).  For more information, visit